Danish biotech Novozymes has linked up with US-based Anuvia Plant Nutrients to develop a range of combined biotechnologies to reduce the need for synthetic fertilizers in...
14.06.2011
- Biotech deals in the $1 billion to $5 billion range are likely to be a sweet spot for drug companies looking to bolster their pipelines through M&A in an increasingly tough...
25.11.2017
- For many years, Switzerland has held the top spot in the World Economic Forum (WEF) competitiveness index. Compared to other countries, Switzerland maintains relatively high levels...
03.07.2012
- When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative...
Investment in UK biotech and life science companies scored a lifetime high in 2021, according to new data from the BioIndustry Association (BIA) and Clarivate.
18.09.2012
- Billionaire German investor Dietmar Hopp is betting another €80 million ($105 million) on CureVac, a pioneer of vaccines based on a molecule related to DNA, in one of the biggest...
15.04.2012
- Merck Serono, the biopharmaceutical division of German drugs and chemicals group Merck KGaA, inaugurated on Sunday a biotech incubator at Inter-Lab, its research and development...
In a deal potentially worth $2 billion, German drugs and agriculture company Bayer is acquiring Vividion Therapeutics, a San Diego-based US biotech. The California...
UK specialty chemicals company Croda International has agreed to buy Solus Biotech, a South Korean company specializing in ceramide and phospholipid technologies and with...
Pfizer is in the early stage of talks to acquire Seagen (formerly Seattle Genetics), a US biotech focused on developing treatments for cancer, according to a report in...